Occupe actuellement un poste chez Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Commercial Officer | Apellis Pharmaceuticals Inc | 20 novembre 2018 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-02-13 | 2024-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
1 148
-1.2%
67,7777 796 USD |
1 148 -1.2% | 67,77 | 77 796 USD | |
2024-01-31 | 2024-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
906
-1.0%
64,1458 109 USD |
906 -1.0% | 64,14 | 58 109 USD | |
2024-01-23 | 2024-01-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
3 413
-3.5%
65,00221 831 USD |
3 413 -3.5% | 65,00 | 221 831 USD | |
2024-01-17 | 2024-01-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
2 235
-2.2%
66,81149 317 USD |
2 235 -2.2% | 66,81 | 149 317 USD | |
2023-05-04 | 2023-05-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-6.2%
82,71413 550 USD |
5 000 -6.2% | 82,71 | 413 550 USD | |
2023-03-07 | 2023-03-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-6.2%
63,84319 200 USD |
5 000 -6.2% | 63,84 | 319 200 USD | |
2023-02-06 | 2023-02-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-6.9%
55,85279 250 USD |
5 000 -6.9% | 55,85 | 279 250 USD | |
2023-01-05 | 2023-01-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-10.4%
50,70253 500 USD |
5 000 -10.4% | 50,70 | 253 500 USD | |
2022-12-07 | 2022-12-05 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-10.4%
50,38251 900 USD |
5 000 -10.4% | 50,38 | 251 900 USD | |
2022-11-07 | 2022-11-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-10.4%
58,54292 700 USD |
5 000 -10.4% | 58,54 | 292 700 USD | |
2022-09-07 | 2022-09-06 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-10.4%
60,38301 900 USD |
5 000 -10.4% | 60,38 | 301 900 USD | |
2022-08-16 | 2022-08-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 500
-22.6%
69,00862 500 USD |
12 500 -22.6% | 69,00 | 862 500 USD | |
2022-08-12 | 2022-08-11 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 500
-22.6%
67,00837 500 USD |
12 500 -22.6% | 67,00 | 837 500 USD | |
2022-08-09 | 2022-08-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 500
-22.6%
65,00812 500 USD |
12 500 -22.6% | 65,00 | 812 500 USD | |
2022-08-04 | 2022-08-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-11.7%
56,43282 150 USD |
5 000 -11.7% | 56,43 | 282 150 USD |